Helsinn grants Taiho rights to oral and IV forms of Netu-palo-FDC to prevent chemotherapy-induced nausea and vomiting (CINV)

Helsinn Healthcare S.A.

Switzerland / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Taiho Pharmaceutical Co. Ltd.

Japan / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced